244 related articles for article (PubMed ID: 14688101)
1. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.
Chen L; Wang J; Zganiacz A; Xing Z
Infect Immun; 2004 Jan; 72(1):238-46. PubMed ID: 14688101
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
Giri PK; Verma I; Khuller GK
J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
[TBL] [Abstract][Full Text] [Related]
3. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
[TBL] [Abstract][Full Text] [Related]
4. Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.
Wang J; Santosuosso M; Ngai P; Zganiacz A; Xing Z
J Immunol; 2004 Oct; 173(7):4590-7. PubMed ID: 15383593
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
[TBL] [Abstract][Full Text] [Related]
7. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
8. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
[TBL] [Abstract][Full Text] [Related]
9. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
[TBL] [Abstract][Full Text] [Related]
11. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs.
Lyadova IV; Vordermeier HM; Eruslanov EB; Khaidukov SV; Apt AS; Hewinson RG
Clin Exp Immunol; 2001 Nov; 126(2):274-9. PubMed ID: 11703371
[TBL] [Abstract][Full Text] [Related]
12. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.
Aguilo N; Toledo AM; Lopez-Roman EM; Perez-Herran E; Gormley E; Rullas-Trincado J; Angulo-Barturen I; Martin C
Clin Vaccine Immunol; 2014 Apr; 21(4):594-7. PubMed ID: 24501340
[TBL] [Abstract][Full Text] [Related]
14. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.
Derrick SC; Kolibab K; Yang A; Morris SL
Clin Vaccine Immunol; 2014 Oct; 21(10):1443-51. PubMed ID: 25143340
[TBL] [Abstract][Full Text] [Related]
16. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
mBio; 2016 May; 7(3):. PubMed ID: 27222470
[TBL] [Abstract][Full Text] [Related]
17. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
18. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
19. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
